BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18775444)

  • 1. 3'-Fluoro substitution in the pyridine ring of epibatidine improves selectivity and efficacy for alpha4beta2 versus alpha3beta4 nAChRs.
    Abdrakhmanova GR; Carroll FI; Damaj MI; Martin BR
    Neuropharmacology; 2008 Dec; 55(8):1287-92. PubMed ID: 18775444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine.
    Avalos M; Parker MJ; Maddox FN; Carroll FI; Luetje CW
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1246-52. PubMed ID: 12183686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs.
    Abdrakhmanova GR; Damaj MI; Carroll FI; Martin BR
    Mol Pharmacol; 2006 Jun; 69(6):1945-52. PubMed ID: 16505153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
    Matsuyama S; Matsumoto A
    J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB; McMahon LR
    Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
    Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
    Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
    Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues of 2'-fluoro-3'-(4-nitrophenyl)deschloroepibatidine.
    Ondachi P; Castro A; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    J Med Chem; 2012 Jul; 55(14):6512-22. PubMed ID: 22742586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
    Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
    Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro.
    Deuther-Conrad W; Patt JT; Feuerbach D; Wegner F; Brust P; Steinbach J
    Farmaco; 2004 Oct; 59(10):785-92. PubMed ID: 15474055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
    Talka R; Salminen O; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volatile anesthetic isoflurane inhibits LTP induction of hippocampal CA1 neurons through α4β2 nAChR subtype-mediated mechanisms.
    Piao MH; Liu Y; Wang YS; Qiu JP; Feng CS
    Ann Fr Anesth Reanim; 2013 Oct; 32(10):e135-41. PubMed ID: 24011619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives.
    Corrie LW; Stokes C; Wilkerson JL; Carroll FI; McMahon LR; Papke RL
    Mol Pharmacol; 2020 Oct; 98(4):328-342. PubMed ID: 32690626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells.
    Karadsheh MS; Shah MS; Tang X; Macdonald RL; Stitzel JA
    J Neurochem; 2004 Dec; 91(5):1138-50. PubMed ID: 15569257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen.
    Ogunjirin AE; Fortunak JM; Brown LL; Xiao Y; Dávila-García MI
    Neurochem Res; 2015 Oct; 40(10):2131-42. PubMed ID: 26508288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.